Analyst Recommendations

Needham analyst issues BUY recommendation for RXRX on March 4, 2024 08:02AM ET. The previous analyst recommendation was Buy.RXRX was trading at $12.81 at issue of the analyst...

March 4, 2024   RXRX 5.60%

Cowen & Co. analyst issues OUTPERFORM recommendation for MTZ on March 4, 2024 07:56AM ET. The previous analyst recommendation was Outperform.MTZ was trading at $84.85 at issue of...

March 4, 2024   MTZ 0.65%

Telsey Advisory analyst issues MARKET PERFORM recommendation for OLPX on March 4, 2024 09:01AM ET. The previous analyst recommendation was Market Perform.OLPX was trading at $1.82 at issue...

March 4, 2024   OLPX -0.73%

Susquehanna analyst issues UNDERPERFORM recommendation for EPAM on March 4, 2024 07:00AM ET. The previous analyst recommendation was Underperform.EPAM was trading at $306.83 at issue of the analyst...

March 4, 2024   EPAM 0.30%

Wells Fargo analyst issues BUY recommendation for COST on March 4, 2024 07:00AM ET. The previous analyst recommendation was Buy.COST was trading at $749.44 at issue of the...

March 4, 2024   COST -0.36%

UBS analyst issues UNDERPERFORM recommendation for COST on March 4, 2024 07:00AM ET. The previous analyst recommendation was Underperform.COST was trading at $749.44 at issue of the analyst...

March 4, 2024   COST -0.36%

Wedbush analyst issues UNDERPERFORM recommendation for AMD on March 4, 2024 07:00AM ET. The previous analyst recommendation was Underperform.AMD was trading at $202.64 at issue of the analyst...

March 4, 2024   AMD -2.08%

Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for GMS on March 4, 2024 06:55AM ET. The previous analyst recommendation was Overweight.GMS was trading at $90.57 at issue of the...

March 4, 2024   GMS 0.05%

Wedbush analyst issues OUTPERFORM recommendation for GMS on March 4, 2024 06:55AM ET. The previous analyst recommendation was Outperform.GMS was trading at $90.57 at issue of the analyst...

March 4, 2024   GMS 0.05%

Wedbush analyst issues BUY recommendation for EPAM on March 4, 2024 07:00AM ET. The previous analyst recommendation was Buy.EPAM was trading at $306.83 at issue of the analyst...

March 4, 2024   EPAM 0.30%